South Korea’s S.Biomedics Surges: 2026 Market Growth & Strategic Innovation
South Korea’s S.Biomedics, a rising biotech star, trades at 16,950 KRW with a 209.93 trillion‑KRW market cap, driven by R&D growth, strategic partnerships, and a strong product pipeline.
2 minutes to read